FDA adverse event reporting is the system for telling the agency when an FDA-regulated product may have harmed someone or malfunctioned. Manufacturers, importers, and certain user facilities like hospitals must file under federal law within product-specific deadlines. Patients, consumers, and most healthcare professionals file voluntarily through the MedWatch program. Vaccines go through a separate system called VAERS, and that is the one area where healthcare providers themselves have a legal duty to report.
Who Has to Report and Who Chooses To
Federal law splits reporters into two groups. Manufacturers, packers, distributors, and importers of regulated products must submit reports, generally electronically in a format the FDA can process and archive.1U.S. Food and Drug Administration. Reporting Serious Problems to FDA Hospitals, nursing homes, and other user facilities that use medical devices carry their own mandatory duties, which look different from those of manufacturers.
Everyone else — patients, family members, and most healthcare professionals — reports voluntarily. There is no penalty for choosing not to file. The FDA still leans heavily on these voluntary reports because they often provide the first real-world signal that a product is causing problems, and a single well-documented report can prompt a label change or a design modification.1U.S. Food and Drug Administration. Reporting Serious Problems to FDA
What Counts as a Reportable Event
The FDA is interested in serious adverse events. Serious has a specific meaning here. It covers outcomes that resulted in death; a life-threatening condition; hospitalization or a prolonged stay; disability or permanent damage; a congenital anomaly from exposure before or during pregnancy; or a medical intervention needed to prevent permanent harm. It also covers other important medical events that may jeopardize the patient, such as severe allergic reactions requiring emergency treatment, serious blood disorders, or drug dependence.2U.S. Food and Drug Administration. What is a Serious Adverse Event
An emergency room visit alone does not qualify unless it also meets one of the other criteria.
Product quality problems are also reportable even when no one has been hurt yet. Suspected contamination, defective packaging, mislabeled instructions, and medication errors all fit within the system. If two products had confusingly similar packaging and you received the wrong dose, that is exactly the kind of report the FDA wants.
Which Products the System Covers
MedWatch accepts reports on prescription and over-the-counter drugs, biologics, medical devices, dietary supplements, cosmetics (including hair dyes, tattoos, and moisturizers), radiation-emitting products, and medical foods.3U.S. Food and Drug Administration. MedWatch: The FDA Safety Information and Adverse Event Reporting Program
Two categories are handled elsewhere. Vaccines go through VAERS (covered below). Tobacco products go through the Center for Tobacco Products. Animal drugs and devices have a separate pathway through the Center for Veterinary Medicine using Form FDA 1932a; for FDA-approved animal products, the agency recommends contacting the drug company first, since the company must forward the report on.4U.S. Food and Drug Administration. How to Report Animal Drug and Device Side Effects and Product Problems
Deadlines for Mandatory Reporters
Deadlines vary by product category, and this is where companies get into trouble. The clock generally starts when the company first receives or becomes aware of the information, not when the event itself happened.
Drugs
Drug manufacturers must file a 15-day alert report for any adverse experience that is both serious and unexpected. Unexpected means not listed in the current labeling, or more severe or more specific than what the label describes. If the label mentions elevated liver enzymes but a patient develops liver failure, that counts as unexpected. Follow-up reports with new information are also due within 15 calendar days.5eCFR. 21 CFR 314.80 – Postmarketing Reporting of Adverse Drug Experiences
Serious events already described in the labeling go into periodic reports rather than alert reports: quarterly during the first three years after approval, then annually. Packers and distributors whose names appear on a drug label but who aren’t the original application holder can either report directly to the FDA or route reports to the application holder within five calendar days.5eCFR. 21 CFR 314.80 – Postmarketing Reporting of Adverse Drug Experiences
Medical Devices
Device manufacturers and importers must report deaths and serious injuries within 30 calendar days of learning that a device may have caused or contributed to the event. The same 30-day deadline applies to malfunctions that could lead to death or serious injury if they happened again.6eCFR. 21 CFR Part 803 – Medical Device Reporting
A faster five-work-day deadline applies when the event requires remedial action to prevent an unreasonable risk to public health, or when the FDA specifically requests a rapid report. Work days here mean Monday through Friday, excluding federal holidays.6eCFR. 21 CFR Part 803 – Medical Device Reporting
User facilities like hospitals and nursing homes report separately. When a device may have caused or contributed to a patient’s death, the facility must report to both the FDA and the device manufacturer within 10 work days. For serious injuries, the report goes to the manufacturer only (or to the FDA if the manufacturer is unknown), again within 10 work days.7eCFR. 21 CFR 803.30 – If I Am a User Facility, What Reporting Requirements Apply to Me
Dietary Supplements and Over-the-Counter Drugs
The Dietary Supplement and Nonprescription Drug Consumer Protection Act requires the “responsible person” — the manufacturer, packer, or distributor whose name appears on the product label — to report any serious adverse event within 15 business days of receiving it.8GovInfo. 21 USC 379aa-1 – Serious Adverse Event Reporting for Dietary Supplements
Tobacco Products
Tobacco product applicants must report serious and unexpected adverse experiences to the Center for Tobacco Products within 15 calendar days, filed through the HHS Safety Reporting Portal.9eCFR. 21 CFR 1114.41 – Reporting Requirements
Vaccines and VAERS
Vaccines go through the Vaccine Adverse Event Reporting System, jointly managed by the FDA and the CDC. Under 42 USC 300aa-25, healthcare providers must report to VAERS any event listed on the Vaccine Injury Table that occurs within the specified time period after vaccination, as well as any event the vaccine manufacturer lists as a contraindication to further doses.10VAERS. VAERS – FAQs
The Vaccine Injury Table pairs specific reactions with specific vaccine categories and time windows. Anaphylaxis within four hours of a tetanus-containing vaccine is a reportable table event. Encephalopathy within 72 hours of a pertussis vaccine is another. Beyond the table, the FDA encourages voluntary reports for any adverse reaction following vaccination, even when the connection is uncertain. Reports that also involve a non-vaccine pharmaceutical product are shared with MedWatch.11U.S. Food and Drug Administration. Vaccine Adverse Event Reporting System (VAERS) Questions and Answers
How to File
MedWatch uses three versions of the same form, and the right one depends on who you are. Form FDA 3500 is for healthcare professionals filing voluntary reports. Form FDA 3500B is a simplified version for consumers and patients. Form FDA 3500A is used by mandatory reporters (manufacturers, user facilities, and IND researchers) when electronic submission is not required.12U.S. Food and Drug Administration. MedWatch Forms for FDA Safety Reporting Most mandatory reporters have to file electronically; the paper 3500A exists as a fallback.
Voluntary reporters can file fastest through MedWatch Online. You can also download Form 3500 or 3500B, complete it, and submit by mail or fax using the instructions on the form. A Spanish-language version of Form 3500B is available with its own mail and fax instructions.12U.S. Food and Drug Administration. MedWatch Forms for FDA Safety Reporting
Before you start, gather what you can. The FDA will accept a report with missing fields, but more detail makes the report more useful:
- Patient age, gender, and weight.
- Product identification: brand name, generic name, manufacturer, lot number, and expiration date. The lot number is especially important because it lets the FDA trace problems to specific production batches.
- Exact dose, how the product was administered, and the dates of use.
- A chronological description of what happened.
- Any treatment given in response to the event.
- Your contact information, in case the FDA follows up.13U.S. Food and Drug Administration. Instructions for Completing Form FDA 3500
The FDA does not give individualized medical advice in response to a report. Filing is a safety surveillance function and is not a substitute for contacting your doctor.
Privacy, HIPAA, and Confidentiality
Fear of exposure is one of the main reasons people hesitate to file. The FDA protects patient identities to the fullest extent of the law and does not disclose the reporter’s identity in response to a Freedom of Information Act request.13U.S. Food and Drug Administration. Instructions for Completing Form FDA 3500 Veterinary reports carry the same protection for both person and animal.4U.S. Food and Drug Administration. How to Report Animal Drug and Device Side Effects and Product Problems
Healthcare providers sometimes worry that filing with the FDA violates HIPAA. It does not. Federal privacy regulations explicitly permit covered entities to disclose protected health information without patient authorization to the FDA for activities related to the quality, safety, or effectiveness of an FDA-regulated product. That exemption specifically covers collecting and reporting adverse events, tracking products, enabling recalls, and conducting post-market surveillance.14eCFR. 45 CFR Part 164 Subpart E – Privacy of Individually Identifiable Health Information
Penalties for Companies That Don’t Report
Mandatory reporters that ignore their obligations face real enforcement risk. The FDA typically starts with a warning letter identifying the violations and demanding corrective action. Beyond that, the agency can seek court injunctions to halt operations, seize products, or pursue criminal prosecution for prohibited acts under the Federal Food, Drug, and Cosmetic Act.
Civil monetary penalties apply to certain postmarket safety violations. For failures related to required postmarket studies, safety labeling changes, or risk management programs, the statutory ceiling is $250,000 per violation and up to $1,000,000 for all violations in a single proceeding. If a company continues violating after written notice from the FDA, the penalty doubles every 30 days and can reach $10,000,000 for all violations in a single proceeding.15GovInfo. 21 USC 333 – Penalties These figures are adjusted upward annually for inflation.16Federal Register. Annual Civil Monetary Penalties Inflation Adjustment
Searching the Public Database
Reports for drugs and biologics feed into the FDA Adverse Event Monitoring System (AEMS), which replaced the older FAERS database. A public dashboard lets anyone search and filter reported events by product name, reaction type, or outcome.17U.S. Food and Drug Administration. FDA Adverse Event Monitoring System (AEMS) Public Dashboard
Read the data carefully. A report in the system does not prove a product caused the event. Reports may be duplicates or incomplete, and the medical information in them is not independently verified. The database cannot tell you how often a particular reaction occurs in the general population, because there is no way to know what share of actual events ever get reported. Use it to spot patterns and prompt questions, not to draw conclusions.